Detalhe da pesquisa
1.
EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphoma.
Blood
; 142(22): 1879-1894, 2023 11 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738652
2.
Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas.
Br J Haematol
; 204(5): 1762-1770, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38500476
3.
Burkitt lymphoma in the modern era: real-world outcomes and prognostication across 30 US cancer centers.
Blood
; 137(3): 374-386, 2021 01 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-32663292
4.
Allogeneic transplant following CAR T-cell therapy for large B-cell lymphoma.
Haematologica
; 108(1): 98-109, 2023 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35833303
5.
Checkpoint inhibitor-based salvage regimens prior to autologous stem cell transplant improve event-free survival in relapsed/refractory classic Hodgkin lymphoma.
Am J Hematol
; 98(3): 464-471, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36629030
6.
Zandelisib with continuous or intermittent dosing as monotherapy or in combination with rituximab in patients with relapsed or refractory B-cell malignancy: a multicentre, first-in-patient, dose-escalation and dose-expansion, phase 1b trial.
Lancet Oncol
; 23(8): 1021-1030, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35835137
7.
NCCN Guidelines® Insights: Hodgkin Lymphoma, Version 2.2022.
J Natl Compr Canc Netw
; 20(4): 322-334, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35390768
8.
Outcomes of Burkitt lymphoma with central nervous system involvement: evidence from a large multicenter cohort study.
Haematologica
; 106(7): 1932-1942, 2021 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33538152
9.
Impact of initial chemotherapy regimen on outcomes for patients with double-expressor lymphoma: A multi-center analysis.
Hematol Oncol
; 39(4): 473-482, 2021 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-34347909
10.
Outcomes of rituximab-BEAM versus BEAM conditioning regimen in patients with diffuse large B cell lymphoma undergoing autologous transplantation.
Cancer
; 126(10): 2279-2287, 2020 05 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-32049359
11.
Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 18(6): 755-781, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32502987
12.
Fludarabine and Busulfan versus Fludarabine, Cyclophosphamide, and Rituximab as Reduced-Intensity Conditioning for Allogeneic Transplantation in Follicular Lymphoma.
Biol Blood Marrow Transplant
; 24(1): 78-85, 2018 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29032272
13.
Autologous Transplantation in Follicular Lymphoma with Early Therapy Failure: A National LymphoCare Study and Center for International Blood and Marrow Transplant Research Analysis.
Biol Blood Marrow Transplant
; 24(6): 1163-1171, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29242111
14.
Autologous transplantation versus allogeneic transplantation in patients with follicular lymphoma experiencing early treatment failure.
Cancer
; 124(12): 2541-2551, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29645093
15.
NCCN Guidelines Insights: Hodgkin Lymphoma, Version 1.2018.
J Natl Compr Canc Netw
; 16(3): 245-254, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29523663
16.
Predictive factors and outcomes for ibrutinib therapy in relapsed/refractory mantle cell lymphoma-a "real world" study.
Hematol Oncol
; 35(4): 528-535, 2017 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-28066928
17.
Hodgkin Lymphoma Version 1.2017, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 15(5): 608-638, 2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-28476741
18.
Impact of Race and Social Determinants of Health on Outcomes in Patients with Aggressive B-cell nHL Treated with CAR-T.
Blood Adv
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38531057
19.
Relevance of Bone Marrow Biopsies for Response Assessment in US National Cancer Institute National Clinical Trials Network Follicular Lymphoma Clinical Trials.
J Clin Oncol
; 41(2): 336-342, 2023 01 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35787017
20.
Overall survival of patients with cHL who progress after autologous stem cell transplant: results in the novel agent era.
Blood Adv
; 7(23): 7295-7303, 2023 12 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-37729621